These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8175969)

  • 1. Chronic baclofen therapy improves the blunted growth hormone response to intravenous arginine in subjects with spinal cord injury.
    Bauman WA; Spungen AM; Zhong YG; Tsitouras PD
    J Clin Endocrinol Metab; 1994 May; 78(5):1135-8. PubMed ID: 8175969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted growth hormone response to intravenous arginine in subjects with a spinal cord injury.
    Bauman WA; Spungen AM; Flanagan S; Zhong YG; Alexander LR; Tsitouras PD
    Horm Metab Res; 1994 Mar; 26(3):152-6. PubMed ID: 8005564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-dose baclofen administration on plasma insulin-like growth factor-I in persons with spinal cord injury.
    Bauman WA; Kirshblum SC; Morrison NG; Cirnigliaro CM; Zhang RL; Spungen AM
    J Clin Pharmacol; 2006 Apr; 46(4):476-82. PubMed ID: 16554457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provocative stimulation of growth hormone: a monozygotic twin study discordant for spinal cord injury.
    Bauman WA; Zhang RL; Spungen AM
    J Spinal Cord Med; 2007; 30(5):467-72. PubMed ID: 18092562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I.
    Skottner A; Clark RG; Fryklund L; Robinson IC
    Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP; Corder R; Pralong FP; Gaillard RC
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations.
    Cohn L; Feller AG; Draper MW; Rudman IW; Rudman D
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):417-25. PubMed ID: 8287568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord.
    Muresanu DF; Sharma A; Lafuente JV; Patnaik R; Tian ZR; Nyberg F; Sharma HS
    Mol Neurobiol; 2015 Oct; 52(2):837-45. PubMed ID: 26126514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum testosterone and growth hormone/insulin-like growth factor-I in adults with spinal cord injury.
    Tsitouras PD; Zhong YG; Spungen AM; Bauman WA
    Horm Metab Res; 1995 Jun; 27(6):287-92. PubMed ID: 7557841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
    Saggese G; Federico G; Cinquanta L
    Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of plasma triglycerides on human growth hormone response to arginine and insulin: a study in hyperlipemics and normal subjects.
    Muggeo M; Tiengo A; Fedele D; Crepaldi G
    Horm Metab Res; 1975 Sep; 7(5):367-74. PubMed ID: 1183914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study.
    Baum HB; Biller BM; Katznelson L; Oppenheim DS; Clemmons DR; Cannistraro KB; Schoenfeld DA; Best SA; Klibanski A
    J Clin Endocrinol Metab; 1996 Jan; 81(1):84-92. PubMed ID: 8550799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
    Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
    J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
    Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
    Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
    Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.